The UK Vaccine Advisory Board said that the Covid-19 vaccine manufactured by AstraZeneca PLC should not be given to people under the age of 30 due to concerns that it can cause fatal blood clots in very rare cases. Said it was desirable.
Wednesday’s decision to limit vaccines for adolescents is a setback in Britain’s flagship inoculation drive, increasing its reliance on Covid-19 shots developed and produced in other countries.
It also hit the vaccine developed by AstraZeneca and the University of Oxford. Despite their safety approvals and tens of millions of doses, these vaccines question their efficacy and potential side effects in more than 70 countries around the world.
Unlike other vaccines, vaccines that do not need to be stored at very low temperatures have been regarded as essential for the deployment of vaccines in poorer countries with a relatively young population.
The speed of the UK’s fast-paced vaccine program should not be influenced by decisions as long as vaccine supply is prolonged, according to UK officials. “This is a course modification to the UK program, if necessary,” said Jonathan Bantam, Deputy Chief Medical Officer of the UK.
The UK limits the AstraZeneca Covid-19 vaccine to people in their 30s and older amid concerns about blood clots
Source link The UK limits the AstraZeneca Covid-19 vaccine to people in their 30s and older amid concerns about blood clots